Abiopharma

News list

Cavalier Jason 🔴 sold 769 shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007760

Full text

News bot Jan. 8, 2026, 9:32 p.m.
🔍 Cavalier Jason (Executive)

Company: Lyra Therapeutics, Inc. (LYRA)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 769
Detailed Transactions and Holdings:
- Sold 769 shares of Common Stock at $3.364 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 518,547.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.